Hi-Tech Pharmacal Co. (NASDAQ: HITK) reported Q2 EPS of $0.71, $0.23 better than the analyst estimate of $0.48 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE